# FDA Inspection 1305912 - Saptalis Pharmaceuticals LLC - March 06, 2026

Source: https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/110d88c7-f70f-498e-9269-9b842cc13af6
Source feed: FDA_Inspections

> FDA Inspection 1305912 for Saptalis Pharmaceuticals LLC on March 06, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305912
- Company Name: Saptalis Pharmaceuticals LLC
- Inspection Date: 2026-03-06
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1283250 - 2025-09-09](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/40933f8b-bc1e-4cd6-aab6-f717cbee79ee)
- [FDA Inspection 1283250 - 2025-09-09](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/a4f7cdc9-dc8b-4a3f-b40a-4f847e018bd2)
- [FDA Inspection 1200278 - 2023-03-17](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/743fd85a-c506-4838-8be4-90c8775b5a06)
- [FDA Inspection 1046656 - 2018-03-28](https://www.keypedia.com/records/fda_inspections/saptalis-pharmaceuticals-llc/73997aa3-6d42-4162-a8ef-f8f8cf2f3ac0)

Company: https://www.keypedia.com/companies/saptalis-pharmaceuticals-llc/7e9c8055-910b-46e4-9d5a-ee86169bc91d

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d